AB Strategic Ventures

AB Strategic Ventures is the corporate venture capital arm of Cencora, a global healthcare solutions provider formerly known as AmerisourceBergen. Established in 2022 with an initial $150 million capital commitment, the fund invests in early-to-mid-stage companies that are transforming healthcare delivery and the pharmaceutical supply chain. Its investment focus includes digital health, patient access, clinical trial innovation, and pharmacy technology. Beyond providing capital, the group offers portfolio companies strategic guidance and access to Cencora's extensive global infrastructure and industry expertise. The fund aims to foster innovation that enhances pharmaceutical distribution and improves patient outcomes worldwide.